CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Revenue:
Asset sales	$ 446	$ 1,850
Commissions and other	946	1,184
Total asset liquidation revenue	1,392	3,034
Patent licensing	200	0
Total revenue	1,592	3,034
Operating costs and expenses:
Asset liquidation	356	1,533
Inventory maintenance	74	3
Patent licensing and maintenance	150	26
Selling, general and administrative	2,394	1,582
Expenses paid to related parties	204	157
Depreciation and amortization	121	3
Total operating costs and expenses	3,299	3,304
Operating Income (Loss) Before Earnings Of Equity Accounted Asset Liquidation Investments	(1,707)	(270)
Earnings of equity accounted asset liquidation investments	802	1,069
Operating income (loss)	(905)	799
Other income (expenses):
Other income	0	10
Interest expense - third party	(95)	(59)
Total other income (expenses)	(95)	(49)
Income (loss) before the undernoted	(1,000)	750
Income tax expense (recovery)	(353)	313
Earnings (loss) of other equity accounted investments (net of tax of $0)	0	(47)
Net income (loss)	(647)	390
Other comprehensive loss:
Currency translation adjustment (net of tax of $0)	(7)	0
Comprehensive income (loss)	$ (654)	$ 390
Weighted average common shares outstanding - basic (in thousands) (in shares)	28,945	27,484
Weighted average common shares outstanding - diluted (in thousands) (in shares)	28,945	27,844
Net income (loss) per share - basic (in dollars per share)	$ (0.02)	$ 0.01
Net income (loss) per share - diluted (in dollars per share)	$ (0.02)	$ 0.01